Literature DB >> 26920244

Dosimetric comparison between step-shoot intensity-modulated radiotherapy and volumetric-modulated arc therapy for upper thoracic and cervical esophageal carcinoma.

Min Gao1, Qilin Li1, Zhonghua Ning1, Wendong Gu1, Jin Huang1, Jinming Mu1, Honglei Pei2.   

Abstract

To compare and analyze the dosimetric characteristics of volumetric modulated arc therapy (VMAT) vs step-shoot intensity-modulated radiation therapy (sIMRT) for upper thoracic and cervical esophageal carcinoma. Single-arc VMAT (VMAT1), dual-arc VMAT (VMAT2), and 7-field sIMRT plans were designed for 30 patients with upper thoracic or cervical esophageal carcinoma. Planning target volume (PTV) was prescribed to 50.4Gy in 28 fractions, and PTV1 was prescribed to 60Gy in 28 fractions. The parameters evaluated included dose homogeneity and conformality, dose to organs at risk (OARs), and delivery efficiency. (1) In comparison to sIMRT, VMAT provided a systematic improvement in PTV1 coverage. The homogeneity index of VMAT1 was better than that of VMAT2. There were no significant differences among sIMRT, VMAT1, and VMAT2 in PTV coverage. (2) VMAT1 and VMAT2 reduced the maximum dose of spinal cord as compared with sIMRT (p < 0.05). The rest dose-volume characteristics of OARs were similar. (3) Monitor units of VMAT2 and VMAT1 were more than sIMRT. However, the treatment time of VMAT1, VMAT2, and sIMRT was (2.0 ± 0.2), (2.8 ± 0.3), and (9.8 ± 0.8) minutes, respectively. VMAT1 was the fastest, and the difference was statistically significant. In the treatment of upper thoracic and cervical esophageal carcinoma by the AXESSE linac, compared with 7-field sIMRT, VMAT showed better PTV1 coverage and superior spinal cord sparing. Single-arc VMAT had similar target volume coverage and the sparing of OAR to dual-arc VMAT, with shortest treatment time and highest treatment efficiency in the 3 kinds of plans.
Copyright © 2016 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dosimetry; Step-shoot intensity-modulated radiation therapy; Upper thoracic and cervical esophageal carcinoma; Volumetric-modulated arc therapy

Mesh:

Year:  2016        PMID: 26920244     DOI: 10.1016/j.meddos.2015.10.007

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  9 in total

1.  Dosimetric comparison and biological evaluation of fixed-jaw intensity-modulated radiation therapy for T-shaped esophageal cancer.

Authors:  Hua Chen; Ying Huang; Hao Wang; Yan Shao; Ning J Yue; Hengle Gu; Yanhua Duan; Aihui Feng; Zhiyong Xu
Journal:  Radiat Oncol       Date:  2021-08-19       Impact factor: 3.481

2.  The Hippocampus Sparing Volume Modulated Arc Therapy does not Influence Plan Quality on Locally Advanced Nasopharyngeal Carcinoma Patients.

Authors:  Wendong Gu; Qilin Li; Dan Xi; Ye Tian; Juncong Mo; Honglei Pei
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

3.  Fixed-jaw technique to improve IMRT plan quality for the treatment of cervical and upper thoracic esophageal cancer.

Authors:  Wei Song; Hong Lu; Jie Liu; Di Zhao; Jun Ma; Biyun Zhang; Dahai Yu; Xinchen Sun; Jinkai Li
Journal:  J Appl Clin Med Phys       Date:  2019-08-28       Impact factor: 2.102

4.  Intensity-Modulated Radiotherapy versus Three-Dimensional Conformal Radiotherapy in Definitive Chemoradiotherapy for Cervical Esophageal Squamous Cell Carcinoma: Comparison of Survival Outcomes and Toxicities.

Authors:  Nai-Bin Chen; Bo Qiu; Jun Zhang; Meng-Yun Qiang; Yu-Jia Zhu; Bin Wang; Jin-Yu Guo; Ling-Zhi Cai; Shao-Min Huang; Meng-Zhong Liu; Qun Li; Yong-Hong Hu; Qi-Wen Li; Hui Liu
Journal:  Cancer Res Treat       Date:  2019-04-30       Impact factor: 4.679

5.  Investigation of Predictors to Achieve Acceptable Lung Dose in T-Shaped Upper and Middle Esophageal Cancer With IMRT and VMAT.

Authors:  Yan Shao; Hua Chen; Hao Wang; Yanhua Duan; Aihui Feng; Ying Huang; Hengle Gu; Qing Kong; Zhiyong Xu
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

6.  Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer.

Authors:  Chen-Xiong Hsu; Kuan-Heng Lin; Shan-Ying Wang; Wei-Ta Tsai; Chiu-Han Chang; Hui-Ju Tien; Pei-Wei Shueng; Tung-Hsin Wu; Greta S P Mok
Journal:  Sci Rep       Date:  2022-02-15       Impact factor: 4.379

7.  Different functional lung-sparing strategies and radiotherapy techniques for patients with esophageal cancer.

Authors:  Pi-Xiao Zhou; Rui-Hao Wang; Hui Yu; Ying Zhang; Guo-Qian Zhang; Shu-Xu Zhang
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

8.  Efficacy of virtual block objects in reducing the lung dose in helical tomotherapy planning for cervical oesophageal cancer: a planning study.

Authors:  Makoto Ito; Hidetoshi Shimizu; Takahiro Aoyama; Hiroyuki Tachibana; Natsuo Tomita; Chiyoko Makita; Yutaro Koide; Daiki Kato; Tsuneo Ishiguchi; Takeshi Kodaira
Journal:  Radiat Oncol       Date:  2018-04-04       Impact factor: 3.481

9.  Dosimetric comparison between modulated arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience.

Authors:  Kyu Hye Choi; Jina Kim; Sea-Won Lee; Young-Nam Kang; HongSeok Jang
Journal:  Radiat Oncol J       Date:  2017-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.